Possible mechanisms of intravenous immunoglobulin treatment in childhood idiopathic thrombocytopenic purpura (ITP).
D000917:Antibody Formation; D000936:Antigen-Antibody Complex / Q000276:immunology; D001323:Autoantibodies / Q000276:immunology; D001379:Azathioprine / Q000627:therapeutic use; D001792:Blood Platelets / Q000276:immunology; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000276:immunology; D007231:Infant, Newborn; D007275:Injections, Intravenous; D007700:Kinetics; D010587:Phagocytosis; D011247:Pregnancy; D011696:Purpura, Thrombocytopenic / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D013156:Splenectomy; D014748:Vinca Alkaloids / Q000627:therapeutic use
D000936:Antigen-Antibody Complex; D001323:Autoantibodies; D007074:Immunoglobulin G; D014748:Vinca Alkaloids; D003520:Cyclophosphamide; D001379:Azathioprine